Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (dc-asgpr)
AssigneeBaylor Research Institute
InventorsSangKon OH, Dapeng LI, Jacques Banchereau, Gerard Zurawski, Sandra Zurawski
Life of this patent
Estimating the term…
Abstract
The present invention includes compositions and methods for making and using anti DC-ASGPR antibodies that can, e.g., activate DCs and other cells.
Claims23
1-13. (canceled)
An anti-DC-ASGPR immunoglobulin or fragment thereof having an autoantigen attached to the immunoglobulin, wherein the immunoglobulin or fragment comprises an immunoglobulin variable heavy chain region from an immunoglobulin heavy chain having the amino acid sequence of SEQ ID NO:
- 5, 7, 9, or 11.
(canceled)
21-29. (canceled)
A method of delivering an antigen to an antigen presenting cell, comprising administering to the antigen presenting cell an effective amount of a composition comprising a recombinant fusion protein, said fusion protein comprising an anti-human dendritic cell asialoglycoprotein receptor (ASGPR) antibody or an antigen binding fragment thereof and one or more autoimmune antigens, wherein the antibody or fragment thereof comprises (a) an immunoglobulin heavy chain selected from the group consisting of SEQ ID NO:
- 5, 7, 9, and 11;
- and (b) an immunoglobulin light chain selected from the group consisting of SEQ ID NO:
- 6, 8, 10, and 12.
A method of decreasing an antibody-mediated immune response to an autoantigen in a subject, comprising the step of administering to the subject an effective amount of a composition comprising a recombinant fusion protein, said fusion protein comprising an anti-human dendritic cell asialoglycoprotein receptor (ASGPR) antibody or an antigen binding fragment thereof and one or more autoimmune antigens, wherein the antibody or fragment thereof comprises (a) an immunoglobulin heavy chain selected from the group consisting of SEQ ID NO:
- 5, 7, 9, and 11;
- and (b) an immunoglobulin light chain selected from the group consisting of SEQ ID NO:
- 6, 8, 10, and 12.
Dependencies are inferred from the claim text.